Global Market Report

Global Next Generation Cancer Diagnostics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 13, 2019
  • PAGES：151
  • REPORT CODE：GMM163126
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Next Generation Cancer Diagnostics witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Next Generation Cancer Diagnostics market is offered. The research provides insights for the global Next Generation Cancer Diagnostics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Next Generation Cancer Diagnostics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Next Generation Cancer Diagnostics Market Segmentations:

    By Players:

    • Thermo Fisher Scientific

    • Myriad Genetics

    • Opko Health

    • Genomic Health

    • F. Hoffmann-La Roche Ltd

    • GE Healthcare

    • Illumina

    • Almac Group

    • Qiagen

    • Novartis AG

    • Koninklijke Philips N.V

    • Cepheid

    • PerkinElmer

    • Sys

    • Agilent Technologies

    • Abbott

    • Janssen Global Services

    • Hologic


    By Types:

    • Next Generation Sequencing

    • QPCR & Multiplexing

    • Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

    • Protein Microarrays

    • DNA Microarrays


    By End-User:

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Cervical Cancer

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Next Generation Cancer Diagnostics Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Next Generation Cancer Diagnostics Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Next Generation Cancer Diagnostics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Next Generation Cancer Diagnostics Market Share by Types

      • 1.3.2 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Next Generation Sequencing from 2014 to 2026

      • 1.3.3 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of QPCR & Multiplexing from 2014 to 2026

      • 1.3.4 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) from 2014 to 2026

      • 1.3.5 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Protein Microarrays from 2014 to 2026

      • 1.3.6 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of DNA Microarrays from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Next Generation Cancer Diagnostics Market Share by End-Users

      • 1.4.2 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Lung Cancer from 2014 to 2026

      • 1.4.3 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Breast Cancer from 2014 to 2026

      • 1.4.4 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

      • 1.4.5 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Cervical Cancer from 2014 to 2026

      • 1.4.6 Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumNext Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Next Generation Cancer Diagnostics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Next Generation Cancer Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Next Generation Sequencing

      • 3.4.2 Market Size and Growth Rate of QPCR & Multiplexing

      • 3.4.3 Market Size and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

      • 3.4.4 Market Size and Growth Rate of Protein Microarrays

      • 3.4.5 Market Size and Growth Rate of DNA Microarrays


    4 Segmentation of Next Generation Cancer Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Next Generation Cancer Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Next Generation Cancer Diagnostics for Lung Cancer

      • 4.4.2 Market Size and Growth Rate of Next Generation Cancer Diagnostics for Breast Cancer

      • 4.4.3 Market Size and Growth Rate of Next Generation Cancer Diagnostics for Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of Next Generation Cancer Diagnostics for Cervical Cancer

      • 4.4.5 Market Size and Growth Rate of Next Generation Cancer Diagnostics for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Next Generation Cancer Diagnostics Production Analysis by Major Regions

    • 5.2 Global Next Generation Cancer Diagnostics Consumption Analysis by Major Regions

    • 5.3 Global Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis


    6 Product Commodity of Next Generation Cancer Diagnostics Market in Major Countries

    • 6.1 Top 5 Export Countries in Next Generation Cancer Diagnostics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Next Generation Cancer Diagnostics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Next Generation Cancer Diagnostics Landscape Analysis

    • 7.1 North America Next Generation Cancer Diagnostics Landscape Analysis by Major Types

    • 7.2 North America Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users

    • 7.3 North America Next Generation Cancer Diagnostics Landscape Analysis by Major Countries

      • 7.3.1 United States Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 7.3.2 Canada Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 7.3.3 Mexico Next Generation Cancer Diagnostics Market Volume and Growth Rate


    8 Europe Next Generation Cancer Diagnostics Landscape Analysis

    • 8.1 Europe Next Generation Cancer Diagnostics Landscape Analysis by Major Types

    • 8.2 Europe Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users

    • 8.3 Europe Next Generation Cancer Diagnostics Landscape Analysis by Major Countries

      • 8.3.1 Germany Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.2 UK Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.3 France Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.4 Italy Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.6 Spain Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.7 Belgium Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.8 Poland Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.9 Russia Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 8.3.10 Turkey Next Generation Cancer Diagnostics Market Volume and Growth Rate


    9 Asia Pacific Next Generation Cancer Diagnostics Landscape Analysis

    • 9.1 Asia Pacific Next Generation Cancer Diagnostics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Next Generation Cancer Diagnostics Landscape Analysis by Major Countries

      • 9.3.1 China Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 9.3.2 Japan Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 9.3.4 India Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 9.3.6 South Korea Next Generation Cancer Diagnostics Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Next Generation Cancer Diagnostics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 10.3.2 Brazil Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 10.3.3 Nigeria Next Generation Cancer Diagnostics Market Volume and Growth Rate

      • 10.3.4 South Africa Next Generation Cancer Diagnostics Market Volume and Growth Rate 

      • 10.3.5 Argentina Next Generation Cancer Diagnostics Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Thermo Fisher Scientific

      • 11.1.1 Thermo Fisher Scientific Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Myriad Genetics

      • 11.2.1 Myriad Genetics Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Opko Health

      • 11.3.1 Opko Health Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Genomic Health

      • 11.4.1 Genomic Health Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 F. Hoffmann-La Roche Ltd

      • 11.5.1 F. Hoffmann-La Roche Ltd Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 GE Healthcare

      • 11.6.1 GE Healthcare Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Illumina

      • 11.7.1 Illumina Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Almac Group

      • 11.8.1 Almac Group Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Qiagen

      • 11.9.1 Qiagen Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Novartis AG

      • 11.10.1 Novartis AG Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Koninklijke Philips N.V

      • 11.11.1 Koninklijke Philips N.V Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Cepheid

      • 11.12.1 Cepheid Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 PerkinElmer

      • 11.13.1 PerkinElmer Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Sys

      • 11.14.1 Sys Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Agilent Technologies

      • 11.15.1 Agilent Technologies Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Abbott

      • 11.16.1 Abbott Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Janssen Global Services

      • 11.17.1 Janssen Global Services Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Hologic

      • 11.18.1 Hologic Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 97 Figures and 165 Tables)

    • Figure Product Picture

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Next Generation Sequencing from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of QPCR & Multiplexing from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR) from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Protein Microarrays from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of DNA Microarrays from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Lung Cancer from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Breast Cancer from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Colorectal Cancer from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Cervical Cancer from 2014 to 2026

    • Figure Global Next Generation Cancer Diagnostics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Next Generation Cancer Diagnostics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Next Generation Cancer Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Next Generation Cancer Diagnostics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Next Generation Cancer Diagnostics by Different Types from 2014 to 2026

    • Table Consumption Share of Next Generation Cancer Diagnostics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Next Generation Sequencing

    • Figure Market Size and Growth Rate of QPCR & Multiplexing

    • Figure Market Size and Growth Rate of Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

    • Figure Market Size and Growth Rate of Protein Microarrays

    • Figure Market Size and Growth Rate of DNA Microarrays

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Next Generation Cancer Diagnostics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Next Generation Cancer Diagnostics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Cervical Cancer

    • Figure Market Size and Growth Rate of Others

    • Table Global Next Generation Cancer Diagnostics Production by Major Regions

    • Table Global Next Generation Cancer Diagnostics Production Share by Major Regions

    • Figure Global Next Generation Cancer Diagnostics Production Share by Major Regions in 2014

    • Figure Global Next Generation Cancer Diagnostics Production Share by Major Regions in 2018

    • Figure Global Next Generation Cancer Diagnostics Production Share by Major Regions in 2026

    • Table Global Next Generation Cancer Diagnostics Consumption by Major Regions

    • Table Global Next Generation Cancer Diagnostics Consumption Share by Major Regions

    • Figure Global Next Generation Cancer Diagnostics Consumption Share by Major Regions in 2014

    • Figure Global Next Generation Cancer Diagnostics Consumption Share by Major Regions in 2018

    • Figure Global Next Generation Cancer Diagnostics Consumption Share by Major Regions in 2026

    • Table North America Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Europe Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Next Generation Cancer Diagnostics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Next Generation Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table North America Next Generation Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Types in 2014

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Types in 2018

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Types in 2026

    • Table North America Next Generation Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table North America Next Generation Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by End-Users in 2014

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by End-Users in 2018

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by End-Users in 2026

    • Table North America Next Generation Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table North America Next Generation Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2014

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2018

    • Figure North America Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2026

    • Figure United States Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Types in 2014

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Types in 2018

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Types in 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by End-Users in 2014

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by End-Users in 2018

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by End-Users in 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Europe Next Generation Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2014

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2018

    • Figure Europe Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2026

    • Figure Germany Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Types in 2014

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Types in 2018

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Types in 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by End-Users in 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2026

    • Figure China Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandNext Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Next Generation Cancer Diagnostics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Next Generation Cancer Diagnostics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Thermo Fisher Scientific

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific

    • Table Product and Service Introduction of Thermo Fisher Scientific

    • Table Company Profile and Development Status of Myriad Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics

    • Figure Sales and Growth Rate Analysis of Myriad Genetics

    • Figure Revenue and Market Share Analysis of Myriad Genetics

    • Table Product and Service Introduction of Myriad Genetics

    • Table Company Profile and Development Status of Opko Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Opko Health

    • Figure Sales and Growth Rate Analysis of Opko Health

    • Figure Revenue and Market Share Analysis of Opko Health

    • Table Product and Service Introduction of Opko Health

    • Table Company Profile and Development Status of Genomic Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genomic Health

    • Figure Sales and Growth Rate Analysis of Genomic Health

    • Figure Revenue and Market Share Analysis of Genomic Health

    • Table Product and Service Introduction of Genomic Health

    • Table Company Profile and Development Status of F. Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F. Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F. Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F. Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of GE Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare

    • Figure Sales and Growth Rate Analysis of GE Healthcare

    • Figure Revenue and Market Share Analysis of GE Healthcare

    • Table Product and Service Introduction of GE Healthcare

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of Almac Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Almac Group

    • Figure Sales and Growth Rate Analysis of Almac Group

    • Figure Revenue and Market Share Analysis of Almac Group

    • Table Product and Service Introduction of Almac Group

    • Table Company Profile and Development Status of Qiagen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qiagen

    • Figure Sales and Growth Rate Analysis of Qiagen

    • Figure Revenue and Market Share Analysis of Qiagen

    • Table Product and Service Introduction of Qiagen

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Koninklijke Philips N.V

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Koninklijke Philips N.V

    • Figure Sales and Growth Rate Analysis of Koninklijke Philips N.V

    • Figure Revenue and Market Share Analysis of Koninklijke Philips N.V

    • Table Product and Service Introduction of Koninklijke Philips N.V

    • Table Company Profile and Development Status of Cepheid

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cepheid

    • Figure Sales and Growth Rate Analysis of Cepheid

    • Figure Revenue and Market Share Analysis of Cepheid

    • Table Product and Service Introduction of Cepheid

    • Table Company Profile and Development Status of PerkinElmer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PerkinElmer

    • Figure Sales and Growth Rate Analysis of PerkinElmer

    • Figure Revenue and Market Share Analysis of PerkinElmer

    • Table Product and Service Introduction of PerkinElmer

    • Table Company Profile and Development Status of Sys

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sys

    • Figure Sales and Growth Rate Analysis of Sys

    • Figure Revenue and Market Share Analysis of Sys

    • Table Product and Service Introduction of Sys

    • Table Company Profile and Development Status of Agilent Technologies

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agilent Technologies

    • Figure Sales and Growth Rate Analysis of Agilent Technologies

    • Figure Revenue and Market Share Analysis of Agilent Technologies

    • Table Product and Service Introduction of Agilent Technologies

    • Table Company Profile and Development Status of Abbott

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott

    • Figure Sales and Growth Rate Analysis of Abbott

    • Figure Revenue and Market Share Analysis of Abbott

    • Table Product and Service Introduction of Abbott

    • Table Company Profile and Development Status of Janssen Global Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Global Services

    • Figure Sales and Growth Rate Analysis of Janssen Global Services

    • Figure Revenue and Market Share Analysis of Janssen Global Services

    • Table Product and Service Introduction of Janssen Global Services

    • Table Company Profile and Development Status of Hologic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hologic

    • Figure Sales and Growth Rate Analysis of Hologic

    • Figure Revenue and Market Share Analysis of Hologic

    • Table Product and Service Introduction of Hologic


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US